Fruquintinib + Paclitaxel Aids Advanced Gastric/Gastroesophageal Junction Cancer
Improvement seen in progression-free survival among patients who had disease progression on first-line chemotherapy
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.